Celgene Collaborates with Exscientia for its AI Drug Discovery Platform

 Celgene Collaborates with Exscientia for its AI Drug Discovery Platform

Celgene Collaborates with Exscientia for its AI Drug Discovery Platform

Shots:

  • Celgene & Exscientia enter into a 3yrs. partnership to accelerate the development of small molecules for three therapeutic programs for Celgene using Exscientia’s Centaur Chemist AI drug discovery platform in oncology & autoimmunity
  • Exscientia to receive $25M upfront & regulatory & commercial milestone on a future sale of products resulting from the collaboration
  • Exscientia’s Centaur Chemist platform improves drug efficacy & speed of delivery of new treatments. Exscientia also collaborated with GSK, Sanofi, Roche, and Evotec for its AI technology

Click here to read full press release/ article | Ref: Exscientia | Image: Endpoints News

Vartika Singh

Vartika Singh is a content writer who loves to write research articles and reports at PharmaShots. She has in-depth knowledge of the life sciences industry including the Pharma and Biotech sectors. Any articles written by her can be contacted at connect@pharmashots.com.

Related post